AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2023
May 16, 2023
31542_dirs_2023-05-16_7c3d22df-25dd-43fc-8051-1c3b63c1c2e1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2023-05-12
Reporting Person: Daly Richard J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-12 | Common Stock, par value $0.001 per share | M | 50000 | $0.79 | Acquired | 148000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-12 | Options to purchase common stock | $0.79 | M | 50000 | Disposed | 2023-06-15 | Common Stock (50000) | Direct |
Footnotes
F1: The option was granted on June 15, 2016 and previously vested in two annual installments.
More from CATALYST PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2025
Dec 30